Comparison of recurrence rate and risk factors in patients with focal adenomyosis with and without medical treatment after conservative surgery
Observational
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
Postoperative medical treatment with GnRH agonists or LNG-IUS significantly reduced recurrence rates in focal adenomyosis patients after conservative surgery.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To compare the recurrence rate and risk factors between conservative surgery followed by medical treatments and conservative surgery-only in patients with focal adenomyosis.
METHODS: This retrospective study was conducted in a single teaching hospital from May 2011 to October 2016. All eligible patients were identified into three groups: surgery-only group, surgery combined with gonadotropin-releasing hormone agonist (GnRHa), and a levonorgestrel-releasing intrauterine system (LNG-IUS) group. The recurrence rate and risk factors were compared among groups using Kaplan-Meier and Cox proportional hazards analyses. Receiver operating characteristic (ROC) curve analysis was applied to determine a cut-off value for identifying recurrence-related risk factors.
RESULTS: A total of 249 postoperative patients with adenomyosis were included in the final analysis with a mean of 41 months of follow up. The recurrence rate at the long-term follow up was significantly lower in intervention groups than in the surgery-only group (P = 0.011). The Cox proportional hazards and ROC analyses showed that a menstrual cycle longer than 26 days (P = 0.026), diameter of lesions <6 cm (P = 0.030), and combination treatment using GnRHa (P = 0.039) or LNG-IUS (P = 0.007) were protective against relapse. The risk of recurrence was lower in patients with anterior (P = 0.034) or fundus (P = 0.038) adenomyosis.
CONCLUSION: Postoperative therapy using GnRHa or LNG-IUS decreases the long-term relapse rate in women undergoing conservative surgery.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (23)
- Abnormal uterine bleeding via openalex
- Conservative surgical treatment of adenomyosis to improve fertility: Controversial values, indications, complications, and pregnancy outcomes via openalex
- Evaluation of Serum CA 125 Levels in Patients with Pelvic Pain Related to Endometriosis via openalex
- Exploring the challenges for a new classification of adenomyosis via openalex
- Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system via openalex
- Fertility outcome of infertile women with adenomyosis treated with the combination of a conservative microsurgical technique and GnRH agonist: long-term follow-up in a series of nine patients via openalex
- Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? via openalex
- Length of Menstrual Cycle and Risk of Endometriosis: A Meta-Analysis of 11 Case-Control Studies via openalex
- Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma via openalex
- Pregnancy after medical therapy of adenomyosis with a gonadotropin-releasing hormone agonist via openalex
- Surgical and medical treatment of adenomyosis via openalex
- Uterine adenomyosis and adenomyoma: the surgical approach via openalex
- W6818121131 via openalex
- W2042677510 via openalex
- W2065386825 via openalex
- W2081898822 via openalex
- W2163445615 via openalex
- W2736858912 via openalex
- W2781620608 via openalex
- W2873462695 via openalex
- W2890798448 via openalex
- W6811854414 via openalex
- W2019524523 via openalex
Cited by (4)
- Microwave ablation of adenomyosis: five-year follow-up and risk factors for recurrence of symptoms 2026
- Alternative treatments of adenomyosis - an update in procedural management and clinical outcomes 2024
- Both adjuvant and maintenance therapies are needed in women with symptomatic adenomyosis after uterus-sparing treatment 2023
- Letter to the editor: Adjuvant or maintenance therapy may be needed in adenomyosis patients after uterus-sparing surgery 2023
Source provenance
- europepmc
- last seen: 2026-10-16T06:09:50.462052+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:37:28.796859+00:00
- unpaywall
- last seen: 2026-10-16T06:24:35.758740+00:00
License: CC0
· commercial use OK